Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors
✍ Scribed by Sebastian Cerdan; Hans Ruedi Lötscher; Basil Künnecke; Joachim Seelig
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 726 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
✦ Synopsis
A highly specific and powerful magnetic resonance imaging contrast agent has been prepared by coating magnetite (Fe,O,) particles with monoclonal antibodies directed against a tumor antigen. The preparation maintains both the immunoreactivity of the monoclonal antibody and the full relaxing capability of the magnetite particle. MRI image contrast by spin-echo methods can be easily induced in a concentration range of 1- 10 &of the antibody-coated magnetite particles.
📜 SIMILAR VOLUMES
## Abstract New tumor‐specific contrast agents for clinical imaging and therapy for cancer are required. To this end Gd‐H (Gd‐hematoporphyrin), Gd‐TCP (Gd‐tetra‐carboranylmethoxyphenyl‐porphyrin), Gd‐DTPA‐WM53, and Gd‐DTPA‐9.2.27 were synthesized and administered by systemic injection to nude mice
A highly specific and effective magnetic resonance imaging (MRI) contrast agent was prepared by coating superparamagnetite particles with monoclonal antibodies (MAbs) directed against epidermal growth factor receptors (EGFRs), which are over-expressed in esophageal squamous cell carcinoma. The prepa
Iron oxide nanoparticles are used in vivo as contrast agents in magnetic resonance imaging. Their widely used polymer coatings are directly involved in their biocompatibility and avoid magnetic aggregation. As these polymer brushes also limit their tissular diffusion due to important hydrodynamic si